“What Medidata brings to the table, in addition to deep subject matter expertise, is the willingness to keep working until it is right. We can’t do that’ was never a phrase we heard from their Professional Services team.”
"We want to use the best in-class technology and we want to combine that with our clinical research."
“A shared culture is the key to any successful partnership – Medidata’s commitment to integrity and to putting the client at the center of its work aligns perfectly with palleos’ values.”
“Our partnership with Medidata has enabled us to offer top-notch service to sponsors. In the last decade, we’ve embraced the latest Rave EDC technology, including eCOA/ePRO via the Patient Cloud and Rave Coder. We’ve successfully configured intricate study designs, from early-phase oncology with numerous protocol changes to rare disease studies with diverse data collection methods.”
"The Medidata products are very innovative and support our very complex oncology studies."
”Having the RTSM, Coder, and Rave EDC, all [on] one platform makes the integration much more seamless…My reason why I would suggest using Medidata is that the service has been great. The response time has been fantastic, and I always know exactly who to go to if an issue arises or [when] I need the build to be done ‘quick lightning,’ The response time from Medidata has been super.”
"Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale. OIG has a strong record of investigating these corporate and institutional frauds, which often involve complex billing frauds, kickbacks, accounting schemes, illegal marketing and physician self-referral arrangements."
“Medidata is a global brand that everyone knows, and everyone is happy to use. The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. And there’s a lot of confidence in that.”
“We used to do all the reconciliation manually. With the Rave Site Payment, it’s automated the payments not only from a sponsor’s perspective but also from the site’s perspective. Sites don’t have to do anything additional. From a sponsor perspective, we have all the line item details. We can see what’s paid to the site [and] what’s outstanding. The same applies to the sites. They can go into the system, see what’s been paid and what’s outstanding, and then work collaboratively to fix or expedite things if needed.”
“One of the things that attracted me to Medidata was their ability to have a support mechanism [beyond] internal experts. Having a broad reach across the globe and supporting end users with devices are important. These factors attracted me to the Medidata DCT Program because not all competitors have that reach with their help desk and device support. It’s nice to have a reputable organization that allows us to lean on."
"Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."
“By using a system - that both the pharmaceutical industry recognizes, and the regulators accept - to execute high quality clinical trials, our mission to bring better treatments to patients faster can, ultimately, be realized.”
"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."
“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”
"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”